The company recently guided for FY24 revenue of $428M-$432M, consensus $430.97M. Analysts expect the company to report FY25 revenue of $543.99. Guidance taken from Investor Day. Shares of TransMedics (TMDX) are down 3.4% in afternoon trading.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX: